The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Pacira BioSciences, Inc. ("Pacira" or "the Company") (NASDAQ:PCRX ...
NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Pacira BioSciences, Inc. ("Pacira" or the "Company") (NASDAQ: PCRX) of a class action securities lawsuit.
A lawsuit was filed for certain investors in Pacira BioSciences, Inc. (NASDAQ: PCRX) shares. Investors who purchased shares of Pacira ...
Welcome to the Pacira BioSciences Fourth Quarter 2024 Conference ... This increase over 2024 is largely driven by our 200-liter suite in San Diego, which began producing commercial supply in ...
Pacira BioSciences, Inc., is a global leader in the nonopioid pain management and regenerative medicine spaces, with a commitment to helping advance and improve the patient journey along the ...
Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Pacira BioSciences, Inc. (NASDAQ: PCRX) secu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results